Walleye Trading’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,727
Closed -$3.47K 4610
2024
Q3
$3.47K Hold
25,727
﹤0.01% 3876
2024
Q2
$6.95K Hold
25,727
﹤0.01% 3923
2024
Q1
$16.2K Hold
25,727
﹤0.01% 4242
2023
Q4
$36.8K Hold
25,727
﹤0.01% 4397
2023
Q3
$39.6K Hold
25,727
﹤0.01% 4262
2023
Q2
$45.6K Sell
25,727
-15,232
-37% -$28.5K ﹤0.01% 3982
2023
Q1
$41K Hold
40,959
﹤0.01% 4121
2022
Q4
$40.5K Sell
40,959
-24,793
-38% -$21.2K ﹤0.01% 4247
2022
Q3
$13K Hold
65,752
﹤0.01% 4497
2022
Q2
$12K Hold
65,752
﹤0.01% 4608
2022
Q1
$18K Hold
65,752
﹤0.01% 4783
2021
Q4
$23K Hold
65,752
﹤0.01% 4894
2021
Q3
$26K Hold
65,752
﹤0.01% 4808
2021
Q2
$33K Buy
65,752
+6,840
+12% +$3.08K ﹤0.01% 4736
2021
Q1
$27K Sell
58,912
-107
-0.2% -$69 ﹤0.01% 4485
2020
Q4
$40K Sell
59,019
-108,117
-65% -$59.3K ﹤0.01% 4249
2020
Q3
$89K Buy
167,136
+3,246
+2% +$1.45K ﹤0.01% 3447
2020
Q2
$77K Sell
163,890
-58,616
-26% -$13.7K ﹤0.01% 3638
2020
Q1
$20K Sell
222,506
-2,000
-0.9% -$299 ﹤0.01% 3631
2019
Q4
$20K Sell
224,506
-4,501
-2% -$1.03K ﹤0.01% 3992
2019
Q3
$41K Sell
229,007
-3,360
-1% -$643 ﹤0.01% 3623
2019
Q2
$46K Sell
232,367
-29,700
-11% -$5.97K ﹤0.01% 3569
2019
Q1
$42K Buy
262,067
+251,067
+2,282% +$49.7K ﹤0.01% 3781
2018
Q4
$4K Buy
+11,000
New +$3.53K ﹤0.01% 4498

Other funds holding RVPHW

Walleye Trading's RVPHW Position: Q4 2024 in Review

Walleye Trading sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q4 2024, closing a stake of 25,727 shares — an estimated $3.47K sold.

Walleye Trading first reported a position in RVPHW in Q4 2018 and held it in 24 quarters. The position peaked at $89K in Q3 2020. 2 funds tracked by Wall St. Rank hold RVPHW as of Q4 2024.

  • Walleye Trading reported no remaining Reviva Pharmaceuticals Warrants position as of Q4 2024 after selling out during the quarter.
  • Walleye Trading sold 25,727 Reviva Pharmaceuticals Warrants shares in Q4 2024, an estimated $3.47K.
  • Walleye Trading first reported a position in Reviva Pharmaceuticals Warrants in Q4 2018 and held it in 24 quarters.
  • Walleye Trading's Reviva Pharmaceuticals Warrants position peaked at $89K in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q4 2024.

Based on Walleye Trading's 13F filing for Q4 2024, filed 13 Feb 2025.